Suppr超能文献

选择性 5-羟色胺再摄取抑制剂(SSRIs)和 5-羟色胺去甲肾上腺素再摄取抑制剂(SNRIs)在孕期使用与后代自闭症谱系障碍(ASD)和注意缺陷多动障碍(ADHD)风险:真实效应还是偏差?系统评价和荟萃分析。

Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.

机构信息

School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Hadassah-Hebrew University Medical Centers, Jerusalem, Israel.

出版信息

Curr Neuropharmacol. 2021;19(6):896-906. doi: 10.2174/1570159X19666210303121059.

Abstract

BACKGROUND AND OBJECTIVE

An inconsistent association between exposure to SSRIs and SNRIs and the risk for ASD and ADHD in the Offspring was observed in observational studies. Some suggest that the reported association might be due to unmeasured confounding. We aimed to study this association and to look for sources of bias by performing a systematic review and meta-analysis.

METHODS

Medline, Embase, and the Cochrane Library were searched up to June 2019 for studies reporting on ASD and ADHD in the Offspring following exposure during pregnancy. We followed the PRISMA 2009 guidelines for data selection and extraction. Outcomes were pooled using random- effects models and odds ratios (OR), and 95% confidence intervals (CI) were calculated for each outcome using the adjusted point estimate of each study.

RESULTS

Eighteen studies were included in the meta-analysis. We found an association between SSRIs/ SNRIs prenatal use and the risk for ASD and ADHD (OR=1.42, 95% CI: 1.23-1.65, I=58%; OR=1.26, 95% CI: 1.07-1.49, I2=48%, respectively). Similar findings were obtained in women who were exposed to SSRIs/SNRIs before pregnancy, representing statistically significant association with ASD (OR=1.39, 95% CI: 1.24-1.56, I2=33%) and ADHD (OR=1.63, 95% CI: 1.50-1.78, I=0%) in the Offspring, although they were not exposed to those medications in utero.

CONCLUSIONS

Although we found an association between exposure to SSRIs/SNRIs during pregnancy and the risk for ASD and ADHD, an association with those disorders was also present for exposure pre-pregnancy, suggesting that the association might be due to unmeasured confounding. We are aiming to further assess the role of potential unmeasured confounding in the estimation of the association and perform a network meta-analysis.

摘要

背景与目的

观察性研究发现,SSRIs 和 SNRIs 暴露与后代 ASD 和 ADHD 风险之间的关联不一致。一些人认为,报告的关联可能是由于未测量的混杂因素所致。我们旨在通过系统评价和荟萃分析来研究这种关联,并寻找偏倚的来源。

方法

截至 2019 年 6 月,我们检索了 Medline、Embase 和 Cochrane 图书馆,以查找报告妊娠期间暴露于 SSRIs 和 SNRIs 后后代 ASD 和 ADHD 的研究。我们遵循 PRISMA 2009 指南进行数据选择和提取。使用随机效应模型和比值比(OR)汇总结果,并使用每项研究的调整点估计值计算每个结局的 95%置信区间(CI)。

结果

共有 18 项研究纳入荟萃分析。我们发现 SSRIs/SNRIs 产前使用与 ASD 和 ADHD 风险之间存在关联(OR=1.42,95%CI:1.23-1.65,I=58%;OR=1.26,95%CI:1.07-1.49,I2=48%)。在怀孕前暴露于 SSRIs/SNRIs 的女性中也观察到类似的发现,与 ASD(OR=1.39,95%CI:1.24-1.56,I2=33%)和 ADHD(OR=1.63,95%CI:1.50-1.78,I=0%)的关联具有统计学意义,但她们在子宫内并未暴露于这些药物。

结论

尽管我们发现妊娠期间暴露于 SSRIs/SNRIs 与 ASD 和 ADHD 风险之间存在关联,但在妊娠前暴露于 SSRIs/SNRIs 与这些疾病也存在关联,这表明这种关联可能是由于未测量的混杂因素所致。我们旨在进一步评估潜在未测量的混杂因素在估计关联中的作用,并进行网络荟萃分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c28/8686301/0592cabcada6/CN-19-896_F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验